Alumis ALMS
NASDAQ ALMS
$6.85 -0.36 (-4.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alumis (ALMS) Operating Income (2023 - 2026)

Updated

Alumis (ALMS) recorded Operating Income of -$148.86 million in Q2 2026, compared with -$140.54 million a year earlier.

Analysis

Alumis (ALMS) Operating Income (2023 - 2026) Analysis & Trends

On a TTM basis, Alumis' Operating Income came in at -$501.13 million as of Jun 30, 2026; for FY2025, it came in at -$453.8 million.

  • Across earlier years, Operating Income came in at -$300.75 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Operating Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 7.14 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.43 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 3.16 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.39 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.27 Bn
10 Alumis 852.45 Mn -822.39 Mn - -148.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn
API Access

Alumis Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY